Artwork

Content provided by iHeartPodcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by iHeartPodcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Freeport-McMoRan Higher on Tariffs; Starbucks Overseas Interest; Merck M&A

3:56
 
Share
 

Manage episode 493504168 series 3654950
Content provided by iHeartPodcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by iHeartPodcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

On this episode of Stock Movers:
- Freeport-McMoRan (FCX) is higher this morning as President Trump announced a 50% tariff on copper imports, causing a record spike in New York futures and a drop in the global benchmark. The plan, announced in an apparently off-the-cuff comment to reporters, marks the latest twist in a tumultuous period for industrial commodities, as the US leader aims to encourage more mining and smelting at home. He’s already raised fees on steel and aluminum imports, while probes into flows of multiple other metals are in train.
- Starbucks (SBUX) is gaining after it received proposals from prospective investors in its China business, with most eyeing a controlling stake in the operation, said people familiar with the matter. The company may consider selling a larger holding based on valuation and other factors, although its preferred option was to sell a minority stake to a partner, the people said. Starbucks said it sees "significant long-term potential in China" and wants to "retain a meaningful stake in the business", according to a statement.
- Merck (MRK) shares are higher after it agreed to buy UK biotech Verona Pharma Plc for about $10 billion to offset the looming loss of exclusivity for its top-selling cancer drug. Shares of Verona Pharma (VRNA), for its part, are jumping on the news.
- T-Mobile (TMUS) is lower this morning after getting a downgrade from KeyBanc. KeyBanc Capital Markets cut it to underweight from sector weight, saying the telecom company’s stock underperformance is set to continue and that its “premium valuation is just too high.”

See omnystudio.com/listener for privacy information.

  continue reading

520 episodes

Artwork
iconShare
 
Manage episode 493504168 series 3654950
Content provided by iHeartPodcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by iHeartPodcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

On this episode of Stock Movers:
- Freeport-McMoRan (FCX) is higher this morning as President Trump announced a 50% tariff on copper imports, causing a record spike in New York futures and a drop in the global benchmark. The plan, announced in an apparently off-the-cuff comment to reporters, marks the latest twist in a tumultuous period for industrial commodities, as the US leader aims to encourage more mining and smelting at home. He’s already raised fees on steel and aluminum imports, while probes into flows of multiple other metals are in train.
- Starbucks (SBUX) is gaining after it received proposals from prospective investors in its China business, with most eyeing a controlling stake in the operation, said people familiar with the matter. The company may consider selling a larger holding based on valuation and other factors, although its preferred option was to sell a minority stake to a partner, the people said. Starbucks said it sees "significant long-term potential in China" and wants to "retain a meaningful stake in the business", according to a statement.
- Merck (MRK) shares are higher after it agreed to buy UK biotech Verona Pharma Plc for about $10 billion to offset the looming loss of exclusivity for its top-selling cancer drug. Shares of Verona Pharma (VRNA), for its part, are jumping on the news.
- T-Mobile (TMUS) is lower this morning after getting a downgrade from KeyBanc. KeyBanc Capital Markets cut it to underweight from sector weight, saying the telecom company’s stock underperformance is set to continue and that its “premium valuation is just too high.”

See omnystudio.com/listener for privacy information.

  continue reading

520 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play